See more : Cognor Holding S.A. (COG.WA) Income Statement Analysis – Financial Results
Complete financial analysis of PT Indofarma Tbk (INAF.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Indofarma Tbk, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Société BIC SA (BICEF) Income Statement Analysis – Financial Results
- MetaTech (AP) Inc. (3224.TWO) Income Statement Analysis – Financial Results
- Nitin Spinners Limited (NITINSPIN.NS) Income Statement Analysis – Financial Results
- Spectrum Global Solutions, Inc. (SGSI) Income Statement Analysis – Financial Results
- PT Vale Indonesia Tbk (PTNDY) Income Statement Analysis – Financial Results
PT Indofarma Tbk (INAF.JK)
About PT Indofarma Tbk
PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory. It also provides COVID-19 test services, including rapid diagnostic test antigen; reverse transcription polymerase chain reaction, and genose. The company also exports its products. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk operates as a subsidiary of PT. Bio Farma.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 523.60B | 1,144.11B | 2,901.99B | 1,715.59B | 1,359.18B | 1,592.98B | 1,631.32B | 1,674.70B | 1,621.90B | 1,381.44B | 1,337.50B | 1,156.05B | 1,203.47B | 1,047.92B | 1,125.06B | 1,478.59B | 1,273.16B | 1,026.68B | 684.04B |
| Cost of Revenue | 695.56B | 1,254.22B | 2,450.33B | 1,314.99B | 1,108.82B | 1,308.76B | 1,348.50B | 1,337.79B | 1,291.84B | 1,069.01B | 999.93B | 788.15B | 807.28B | 729.45B | 820.42B | 1,145.18B | 983.21B | 770.72B | 484.77B |
| Gross Profit | -171.96B | -110.11B | 451.65B | 400.60B | 250.36B | 284.22B | 282.81B | 336.91B | 330.05B | 312.43B | 337.57B | 367.90B | 396.18B | 318.46B | 304.64B | 333.40B | 289.95B | 255.96B | 199.27B |
| Gross Profit Ratio | -32.84% | -9.62% | 15.56% | 23.35% | 18.42% | 17.84% | 17.34% | 20.12% | 20.35% | 22.62% | 25.24% | 31.82% | 32.92% | 30.39% | 27.08% | 22.55% | 22.77% | 24.93% | 29.13% |
| Research & Development | 592.43M | 552.77M | 763.95M | 501.24M | 306.17M | 326.87M | 2.42B | 3.19B | 3.64B | 1.03B | 1.59B | 1.08B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 115.82B | 42.94B | 45.75B | 41.16B | 31.80B | 30.90B | 28.77B | 35.36B | 28.76B | 31.95B | 57.82B | 40.89B | 110.64B | 92.08B | 83.15B | 80.03B | 77.49B | 66.21B | 57.57B |
| Selling & Marketing | 98.69B | 48.52B | 43.73B | 44.96B | 36.44B | 50.49B | 68.03B | 87.08B | 93.26B | 95.84B | 106.68B | 87.04B | 193.58B | 169.93B | 175.58B | 190.36B | 167.76B | 127.51B | 106.63B |
| SG&A | 216.13B | 91.46B | 89.48B | 86.12B | 68.24B | 81.38B | 96.79B | 122.44B | 122.02B | 127.80B | 164.50B | 127.94B | 304.23B | 262.02B | 258.73B | 270.38B | 245.24B | 193.72B | 164.19B |
| Other Expenses | 222.46B | 246.79B | 305.40B | 212.23B | 172.38B | -7.24B | -1.98B | -602.32M | 1.56B | 3.43B | -3.44B | 1.45B | -3.88B | -9.09B | 565.63M | -8.94B | -8.64B | -6.97B | 202.86M |
| Operating Expenses | 439.18B | 338.25B | 394.89B | 298.35B | 240.62B | 303.58B | 281.95B | 299.68B | 271.73B | 271.75B | 354.00B | 284.39B | 304.23B | 262.02B | 258.73B | 270.38B | 245.24B | 193.72B | 164.19B |
| Cost & Expenses | 1,127.06B | 1,592.47B | 2,845.22B | 1,613.34B | 1,349.44B | 1,612.34B | 1,630.46B | 1,637.47B | 1,563.57B | 1,340.76B | 1,353.93B | 1,072.54B | 1,111.51B | 991.47B | 1,079.15B | 1,415.57B | 1,228.45B | 964.44B | 648.96B |
| Interest Income | 5.56B | 4.54B | 1.84B | 1.10B | 393.10M | 287.79M | 401.74M | 699.77M | 257.07M | 493.64M | 762.46M | 531.16M | 1.21B | 1.05B | 2.24B | 1.37B | 819.28M | 26.53M | 24.92M |
| Interest Expense | 60.49B | 38.08B | 42.96B | 38.25B | 36.76B | 48.17B | 51.33B | 47.26B | 36.90B | 35.30B | 22.09B | 17.00B | 18.15B | 22.35B | 35.34B | 30.27B | 16.12B | 16.44B | 15.58B |
| Depreciation & Amortization | 27.64B | 32.12B | 34.60B | 28.27B | 20.43B | 33.00B | 34.80B | 21.87B | 2.97B | 5.98B | 2.90B | 4.27B | 12.04B | 3.28B | 5.53B | -23.70B | -6.56B | -3.05B | -2.16B |
| EBITDA | -581.38B | -479.11B | 86.68B | 86.76B | 70.76B | 55.87B | 30.51B | 55.38B | 62.54B | 49.05B | -20.62B | 85.84B | 87.24B | 56.45B | 45.91B | 40.14B | 38.19B | 59.19B | 32.92B |
| EBITDA Ratio | -111.04% | -38.51% | 2.46% | 5.93% | 1.82% | -0.60% | 1.36% | 2.65% | 3.86% | 3.71% | -2.98% | 7.37% | 8.64% | 5.70% | 4.57% | 2.66% | 3.00% | 5.76% | 4.81% |
| Operating Income | -603.46B | -479.54B | 51.98B | 87.66B | 16.94B | 25.91B | 2.46B | 37.23B | 58.33B | 40.68B | -16.43B | 78.44B | 91.96B | 56.45B | 45.91B | 63.02B | 44.71B | 62.23B | 35.08B |
| Operating Income Ratio | -115.25% | -41.91% | 1.79% | 5.11% | 1.25% | 1.63% | 0.15% | 2.22% | 3.60% | 2.94% | -1.23% | 6.79% | 7.64% | 5.39% | 4.08% | 4.26% | 3.51% | 6.06% | 5.13% |
| Total Other Income/Expenses | -66.05B | -200.59B | -43.21B | -40.09B | -40.31B | -51.21B | -52.53B | -56.15B | -37.23B | -33.28B | -46.60B | -16.71B | -24.17B | -36.04B | -33.24B | -53.15B | -22.64B | -22.17B | -19.04B |
| Income Before Tax | -669.51B | -517.56B | 8.77B | 18.08B | 9.75B | -25.30B | -56.82B | -18.92B | 14.18B | 7.40B | -63.03B | 61.73B | 55.20B | 20.41B | 12.67B | 9.87B | 22.07B | 40.06B | 16.04B |
| Income Before Tax Ratio | -127.87% | -45.24% | 0.30% | 1.05% | 0.72% | -1.59% | -3.48% | -1.13% | 0.87% | 0.54% | -4.71% | 5.34% | 4.59% | 1.95% | 1.13% | 0.67% | 1.73% | 3.90% | 2.34% |
| Income Tax Expense | 51.49B | -89.07B | 46.34B | 18.05B | 1.78B | 7.44B | -10.53B | -1.55B | 7.61B | 6.24B | -8.81B | 19.35B | 18.28B | 7.86B | 10.54B | 4.83B | 11.00B | 24.82B | 6.44B |
| Net Income | -720.99B | -428.49B | -37.57B | 27.58M | 7.96B | -32.74B | -46.28B | -17.37B | 6.57B | 1.17B | -54.22B | 42.38B | 36.92B | 12.55B | 2.13B | 5.03B | 11.08B | 15.24B | 9.59B |
| Net Income Ratio | -137.70% | -37.45% | -1.29% | 0.00% | 0.59% | -2.06% | -2.84% | -1.04% | 0.40% | 0.08% | -4.05% | 3.67% | 3.07% | 1.20% | 0.19% | 0.34% | 0.87% | 1.48% | 1.40% |
| EPS | -232.63 | -138.25 | -12.12 | 0.01 | 2.57 | -10.56 | -14.93 | -5.60 | 2.12 | 2.02 | -17.50 | 13.68 | 11.93 | 4.05 | 0.69 | 0.02 | 3.57 | 4.92 | 3.10 |
| EPS Diluted | -232.63 | -138.25 | -12.12 | 0.01 | 2.57 | -10.56 | -14.93 | -5.60 | 2.12 | 2.02 | -17.50 | 13.68 | 11.93 | 4.05 | 0.69 | 0.02 | 3.57 | 4.92 | 3.10 |
| Weighted Avg Shares Out | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.07B | 3.10B | 3.10B | 3.09B | 3.10B | 3.08B | 3.10B | 3.10B | 3.10B | 3.10B |
| Weighted Avg Shares Out (Dil) | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.10B | 3.09B | 3.10B | 3.08B | 3.10B | 3.10B | 3.10B | 3.10B |
Source: https://incomestatements.info
Category: Stock Reports